
Gland Pharma Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Gland Pharma receives approval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials".
Filed with NSE · · 2 pages · English

Gland Pharma Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Gland Pharma receives approval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials".
Follow Gland Pharma into a list and get an email when it puts out news.
Follow Gland Pharma